NYSEARCA:BWV

iPath CBOE S&P 500 BuyWrite ETN (BWV) Price, Holdings, & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$76.89
$77.50
50-Day Range
N/A
52-Week Range
$71.68
$80.07
Volume
1,999 shs
Average Volume
62,280 shs
Market Capitalization
$1.23 billion
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.00%
BWV stock logo

About iPath CBOE S&P 500 BuyWrite ETN (NYSEARCA:BWV)

Blue Water Vaccines Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges. Blue Water Vaccines Inc. is headquartered in Cincinnati, OH.

BWV ETF News Headlines

See More Headlines
Receive BWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath CBOE S&P 500 BuyWrite ETN and its competitors with MarketBeat's FREE daily newsletter.

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

iPath CBOE S&P 500 BuyWrite ETN (BWV)


BWV ETF - Frequently Asked Questions

Should I buy or sell iPath CBOE S&P 500 BuyWrite ETN stock right now?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iPath CBOE S&P 500 BuyWrite ETN in the last twelve months. There are currently for the stock. The consensus among Wall Street analysts is that investors should "n/a" BWV shares.
View BWV analyst ratings
or view top-rated stocks.

What is iPath CBOE S&P 500 BuyWrite ETN's stock price target for 2024?

0 Wall Street research analysts have issued 12 month price targets for iPath CBOE S&P 500 BuyWrite ETN's shares. Their BWV share price targets range from $0.00 to $0.00. On average, they expect the company's stock price to reach $0.00 in the next year. This suggests that the stock has a possible downside of 100.0%.
View analysts price targets for BWV
or view top-rated stocks among Wall Street analysts.

This page (NYSEARCA:BWV) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners